Advances in the Management of Chronic Cough and Severe Asthma
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Respiratory Medicine".
Deadline for manuscript submissions: 20 July 2026 | Viewed by 2728
Special Issue Editor
2. Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain
3. Pulmonology Department, Hospital Clínic, Universitat de Barcelona, 08036 Barcelona, Spain
Interests: asthma; chronic cough; biomarkers; exacerbations; biologics; precision medicine; airway inflammation; pediatric asthma;
Special Issue Information
Dear Colleagues,
Cough and asthma remain leading causes of respiratory consultations worldwide, with substantial impact on quality of life and healthcare utilization. This Special Issue will highlight advances that enable more precise, effective, and timely management across ages and phenotypes. We welcome state-of-the-art reviews and original research on diagnostic pathways for chronic cough, endotyping and biomarkers in asthma (including type-2 and non-type-2 inflammation), imaging and lung function tools, and multimorbidity (e.g., rhinitis, CRSwNP, GERD). We also encourage submissions on severe asthma, exacerbation prevention, pediatric considerations, and implementation science to bridge guidelines and real-world practice. Our aim is to provide clinicians and researchers with practical, high-quality evidence to improve outcomes for people living with cough and asthma.
Dr. Ebymar Arismendi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- asthma
- chronic cough
- biomarkers
- exacerbations
- biologics
- precision medicine
- airway inflammation
- pediatric asthma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
